CRNX
Price
$33.01
Change
+$0.69 (+2.13%)
Updated
Jun 6 closing price
Capitalization
3.03B
62 days until earnings call
QURE
Price
$17.27
Change
+$0.66 (+3.97%)
Updated
Jun 6 closing price
Capitalization
945.51M
54 days until earnings call
Interact to see
Advertisement

CRNX vs QURE

Header iconCRNX vs QURE Comparison
Open Charts CRNX vs QUREBanner chart's image
Crinetics Pharmaceuticals
Price$33.01
Change+$0.69 (+2.13%)
Volume$496.64K
Capitalization3.03B
uniQure
Price$17.27
Change+$0.66 (+3.97%)
Volume$1.81M
Capitalization945.51M
CRNX vs QURE Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. QURE commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and QURE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (CRNX: $33.01 vs. QURE: $17.27)
Brand notoriety: CRNX and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 52% vs. QURE: 91%
Market capitalization -- CRNX: $3.03B vs. QURE: $945.51M
CRNX [@Biotechnology] is valued at $3.03B. QURE’s [@Biotechnology] market capitalization is $945.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, QURE is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 5 TA indicator(s) are bullish while QURE’s TA Score has 5 bullish TA indicator(s).

  • CRNX’s TA Score: 5 bullish, 3 bearish.
  • QURE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than QURE.

Price Growth

CRNX (@Biotechnology) experienced а +8.19% price change this week, while QURE (@Biotechnology) price change was +19.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

QURE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.03B) has a higher market cap than QURE($946M). QURE YTD gains are higher at: -2.208 vs. CRNX (-35.439). QURE has higher annual earnings (EBITDA): -160.74M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. QURE (368M). CRNX has less debt than QURE: CRNX (50.8M) vs QURE (66.1M). QURE has higher revenues than CRNX: QURE (27.1M) vs CRNX (760K).
CRNXQURECRNX / QURE
Capitalization3.03B946M320%
EBITDA-373.49M-160.74M232%
Gain YTD-35.439-2.2081,605%
P/E RatioN/AN/A-
Revenue760K27.1M3%
Total Cash1.27B368M346%
Total Debt50.8M66.1M77%
FUNDAMENTALS RATINGS
CRNX vs QURE: Fundamental Ratings
CRNX
QURE
OUTLOOK RATING
1..100
1319
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
5198
PRICE GROWTH RATING
1..100
6335
P/E GROWTH RATING
1..100
10091
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QURE's Valuation (82) in the Biotechnology industry is in the same range as CRNX (92) in the Pharmaceuticals Major industry. This means that QURE’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (66) in the Pharmaceuticals Major industry is somewhat better than the same rating for QURE (100) in the Biotechnology industry. This means that CRNX’s stock grew somewhat faster than QURE’s over the last 12 months.

CRNX's SMR Rating (51) in the Pharmaceuticals Major industry is somewhat better than the same rating for QURE (98) in the Biotechnology industry. This means that CRNX’s stock grew somewhat faster than QURE’s over the last 12 months.

QURE's Price Growth Rating (35) in the Biotechnology industry is in the same range as CRNX (63) in the Pharmaceuticals Major industry. This means that QURE’s stock grew similarly to CRNX’s over the last 12 months.

QURE's P/E Growth Rating (91) in the Biotechnology industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that QURE’s stock grew similarly to CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXQURE
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
74%
Declines
ODDS (%)
Bearish Trend 12 days ago
79%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICERX43.910.07
+0.16%
NYLI Epoch International Chc SIMPLE Cl
USSPX74.32N/A
N/A
Victory 500 Index Member
ARRFX13.55N/A
N/A
AMG River Road Focused Absolute Value N
SGLYX11.12N/A
N/A
SEI Global Managed Volatility Y (SIMT)
FIJDX39.38N/A
N/A
Fidelity Advisor Gold Z

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+2.13%
XNCR - CRNX
59%
Loosely correlated
+5.81%
DYN - CRNX
56%
Loosely correlated
+5.08%
IDYA - CRNX
56%
Loosely correlated
+2.99%
TRDA - CRNX
55%
Loosely correlated
+2.46%
RVMD - CRNX
55%
Loosely correlated
+2.21%
More